The study proposes to investigate, in children admitted at Children's Medical Center at
Dallas, the effectiveness of antimicrobial lock therapy (ALT) with Micafungin in combination
with systemic antifungal therapy in catheter-related fungal infections in order to salvage
highly needed central venous catheter (CVC) and at the same time to investigate the
effectiveness of Micafungin alone as systemic therapy in the treatment of Candidemia in a
pediatric population.
Phase:
Phase 1
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)